Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease.

BACKGROUND & AIMS A few rare monogenic primary immunodeficiencies (PIDs) are characterized by chronic intestinal inflammation that resembles Crohn's disease (CD). We investigated whether 23 genes associated with 10 of these monogenic disorders contain common, low-frequency, or rare variants that increase risk for CD. METHODS Common and low frequency variants in 1 Mb loci centered on the candidate genes were analyzed using meta-data corresponding to genotypes of approximately 17,000 patients with CD or without CD (controls) in Europe. The contribution of rare variants was assessed by high-throughput sequencing of 4750 individuals, including 660 early-onset and/or familial cases among the 2390 patients with CD. Variants were expressed from vectors in SW480 or HeLa cells and functions of their products were analyzed in immunofluorescence, luciferase, immunoprecipitation, and immunoblot assays. RESULTS We reproduced the association of the interleukin 10 locus with CD (P = .007), although none of the significantly associated variants modified the coding sequence of interleukin 10. We found XIAP to be significantly enriched for rare coding mutations in patients with CD vs controls (P = .02). We identified 4 previously unreported missense variants associated with CD. Variants in XIAP cause the PID X-linked lymphoproliferative disease type 2, yet none of the carriers of these variants had all the clinical features of X-linked lymphoproliferative disease type 2. Identified XIAP variants S123N, R233Q, and P257A were associated with an impaired activation of NOD2 signaling after muramyl dipeptide stimulation. CONCLUSIONS In a systematic analysis of variants in 23 PID-associated genes, we confirmed the association of variants in XIAP with CD. Further screenings for CD-associated variants and analyses of their functions could increase our understanding of the relationship between PID-associated genes and CD pathogenesis.

[1]  Hailiang Huang,et al.  Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.

[2]  Daniel G. MacArthur,et al.  The ExAC browser: displaying reference data information from over 60 000 exomes , 2016, bioRxiv.

[3]  A. Barabino,et al.  The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency , 2015, BMC Pediatrics.

[4]  Noor B. Dawany,et al.  A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report , 2015, BMC Gastroenterology.

[5]  Hyun-Seung Jin,et al.  Is Whole Exome Sequencing Clinically Practical in the Management of Pediatric Crohn’s Disease? , 2015, Gut and liver.

[6]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[7]  S. Latour,et al.  X-linked Inhibitor of Apoptosis Protein Deficiency: More than an X-linked Lymphoproliferative Syndrome , 2015, Journal of Clinical Immunology.

[8]  S. Latour,et al.  XIAP deficiency syndrome in humans. , 2015, Seminars in cell & developmental biology.

[9]  C. Klein,et al.  The diagnostic approach to monogenic very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[10]  Smita Y. Patel,et al.  Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. , 2014, The Journal of allergy and clinical immunology.

[11]  O. Nielsen,et al.  Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation. , 2014, Trends in molecular medicine.

[12]  M. Silverberg,et al.  Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[13]  K. Schwarz,et al.  A new functional assay for the diagnosis of X‐linked inhibitor of apoptosis (XIAP) deficiency , 2014, Clinical and experimental immunology.

[14]  C. Klein,et al.  Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. , 2014, Immunity.

[15]  R. Andrews,et al.  Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression , 2014, Science.

[16]  P. Rosenstiel,et al.  XIAP variants in male Crohn's disease , 2014, Gut.

[17]  H. Uhlig.  Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease , 2013, Gut.

[18]  K. Schwarz,et al.  X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. , 2013, Clinical immunology.

[19]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[20]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[21]  B. Hartmann,et al.  Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. , 2013, The Journal of allergy and clinical immunology.

[22]  M. Silverberg,et al.  IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[23]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[24]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[25]  Simon C. Potter,et al.  Mapping cis- and trans-regulatory effects across multiple tissues in twins , 2012, Nature Genetics.

[26]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[27]  H. Kanegane,et al.  SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis , 2012, Pediatrics international : official journal of the Japan Pediatric Society.

[28]  J. Puchalka,et al.  Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. , 2012, Gastroenterology.

[29]  Jing Yang,et al.  Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease , 2012, Genes and Immunity.

[30]  T. Merriman,et al.  Clinical and Genetic Risk Factors for Perianal Crohn's Disease in a Population-Based Cohort , 2012, The American Journal of Gastroenterology.

[31]  Judy H. Cho,et al.  NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 , 2011, Gut.

[32]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[33]  F. Rieux-Laucat,et al.  Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel Disease , 2011, The American Journal of Gastroenterology.

[34]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[35]  A. Fischer,et al.  Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). , 2011, Blood.

[36]  Isabelle Cleynen,et al.  Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease , 2011, Nature Genetics.

[37]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[38]  N. Sebire,et al.  Infant colitis—it's in the genes , 2010, The Lancet.

[39]  C. Duckett,et al.  XIAP as a ubiquitin ligase in cellular signaling , 2010, Cell Death and Differentiation.

[40]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[41]  J. B. Garrison,et al.  XIAP mediates NOD signaling via interaction with RIP2 , 2009, Proceedings of the National Academy of Sciences.

[42]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[43]  J. Todd,et al.  Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes , 2009, Science.

[44]  M. Novelli,et al.  Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease , 2009, The American Journal of Gastroenterology.

[45]  Judy H Cho,et al.  Inflammatory bowel disease. , 2009, The New England journal of medicine.

[46]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[47]  A. Ventura,et al.  IBD and IBD mimicking enterocolitis in children younger than 2 years of age , 2009, European Journal of Pediatrics.

[48]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[49]  T. Merriman,et al.  Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort , 2008, Genes and Immunity.

[50]  W. Bodmer,et al.  Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.

[51]  J. Kaplan,et al.  Chediak-Higashi syndrome , 2008, Current opinion in hematology.

[52]  Peter J. Murray,et al.  Cutting Edge: A Transcriptional Repressor and Corepressor Induced by the STAT3-Regulated Anti-Inflammatory Signaling Pathway1 , 2007, The Journal of Immunology.

[53]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[54]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[55]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[56]  J. Korzenik,et al.  Association of glycogen storage disease 1b and Crohn disease: results of a North American survey , 2007, European Journal of Pediatrics.

[57]  F. Rieux-Laucat,et al.  XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome , 2006, Nature.

[58]  D. Sachar,et al.  Granulomatous Enterocolitis Associated with Hermansky-Pudlak Syndrome , 2006, The American Journal of Gastroenterology.

[59]  G. Salvesen,et al.  Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family , 2006, EMBO reports.

[60]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[61]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[62]  E. Seidman,et al.  Leucocyte adhesion deficiency presenting as a chronic ileocolitis. , 1996, Gut.

[63]  S. Katz,et al.  Crohn's disease associated with cyclic neutropenia. , 1992, The American journal of gastroenterology.

[64]  M. Peppercorn,et al.  Crohn's disease associated with autoimmune neutropenia. , 1991, Journal of clinical gastroenterology.

[65]  K. Ueda,et al.  Chediak-Higashi syndrome with intestinal complication. Report of a case. , 1987, Journal of clinical gastroenterology.